Evaluating a Digital Platform Based on Enhanced Recovery After Surgery to Shorten Hospital Stay After Coronary Artery Bypass Grafting in Sao Paulo

What this Trial Is About

Cardiovascular diseases remain the leading cause of death worldwide, with coronary artery disease being a major contributor. This research focuses on patients undergoing coronary artery bypass grafting CABG, a common cardiac surgery primarily funded by the Unified Health System in Brazil. The study aims to evaluate the impact of a technology platform based on the Enhanced Recovery After Surgery ERAS concept, which promotes multidisciplinary protocols to help patients recover faster, reduce complications, and shorten hospital stays. Participants in this trial will be divided into two groups. One group will receive standard care for CABG as provided by their treating institution. The other group will follow a modified ERAS-based protocol supported by a digital platform designed to assist patient preparation and recovery. This platform includes pre-operative evaluations, scheduling, communication tools for patients, families, and care teams, and monitoring of recovery up to 30 days after hospital discharge. During the study, participants will be monitored for their length of hospital stay up to 30 days after surgery. Additional assessments include the completeness of protocol steps within one week after surgery, morbidity and mortality rates, and patient-reported outcomes and experiences up to six months post-surgery. The trial is randomized and parallel in design, with no masking, and aims to improve recovery processes and sustainability of cardiac surgery programs.

Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project